Lead Product(s) : Difluorocyclohexyloxyphenol
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Allergan Aesthetics
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Sirona Biochem Announces Exclusive Global Licensing Agreement with Allergan Aesthetics
Details : Under Licensing agreement with Sirona, pursuant to which Allergan Aesthetics will develop and commercialize topical skin care treatments based on active ingredients derived from certain of Sirona’s patents for TFC-1067 (Difluorocyclohexyloxyphenol) and...
Brand Name : TFC-1067
Molecule Type : Small molecule
Upfront Cash : Undisclosed
June 13, 2022
Lead Product(s) : Difluorocyclohexyloxyphenol
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Allergan Aesthetics
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Lead Product(s) : Difluorocyclohexyloxyphenol
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : RODAN & FIELDS LLC
Deal Size : Undisclosed
Deal Type : Termination
Sirona Biochem Announces the Termination of Supply Agreement with Rodan + Fields
Details : Under the terms of the agreement, Sirona will manufacture and supply TFC-1067 (difluorocyclohexyloxyphenol), a novel, new skin brightening ingredient, for use by Rodan + Fields on a non-exclusive basis and Rodan + Fields will launch a new product incorpo...
Brand Name : TFC-1067
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 16, 2022
Lead Product(s) : Difluorocyclohexyloxyphenol
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : RODAN & FIELDS LLC
Deal Size : Undisclosed
Deal Type : Termination
Lead Product(s) : Difluorocyclohexyloxyphenol
Therapeutic Area : Dermatology
Study Phase : Undisclosed
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Sirona Biochem Ships First Batch of TFC-1067 to Rodan + Fields
Details : Sirona has made its first shipment of compound, TFC-1067 to Rodan + Fields. Rodan + Fields will be the first to market for a consumer product utilizing TFC-1067 for the treatment of dyschromia.
Brand Name : TFC-1067
Molecule Type : Small molecule
Upfront Cash : Not Applicable
June 16, 2020
Lead Product(s) : Difluorocyclohexyloxyphenol
Therapeutic Area : Dermatology
Highest Development Status : Undisclosed
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?